The Impact of Worsening Heart Failure in the United States.
Data(s) |
01/10/2015
|
---|---|
Formato |
603 - 614 |
Identificador |
http://www.ncbi.nlm.nih.gov/pubmed/26462100 S1551-7136(15)00057-4 Heart Fail Clin, 2015, 11 (4), pp. 603 - 614 1551-7136 |
Relação |
Heart Fail Clin 10.1016/j.hfc.2015.07.004 |
Palavras-Chave | #Clinical trials #Medications #Outcomes #Worsening heart failure #Acute Disease #Clinical Trials as Topic #Heart Failure #Hospitalization #Humans #Incidence #Registries #United States |
Tipo |
Journal Article |
Cobertura |
United States |
Resumo |
In-hospital worsening heart failure represents a clinical scenario wherein a patient hospitalized for acute heart failure experiences a worsening of their condition, requiring escalation of therapy. Worsening heart failure is associated with worse in-hospital and postdischarge outcomes. Worsening heart failure is increasingly being used as an endpoint or combined endpoint in clinical trials, as it is unique to episodes of acute heart failure and captures an important event during the inpatient course. While prediction models have been developed to identify worsening heart failure, there are no known FDA-approved medications associated with decreased worsening heart failure. Continued study is warranted. |
Idioma(s) |
ENG |